Retrospective Study of Chemotherapy-Induced Peripheral Neuropathy in Gastrointestinal Cancer Patients Receiving Oxaliplati
Not Applicable
- Conditions
- Colon cancer, gastric cancer, esophageal cancer, pancreatic cancer, biliary tract cancer, small intestine cancer, appendix cancer
- Registration Number
- JPRN-UMIN000052950
- Lead Sponsor
- St. Marianna Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Not provided
Exclusion Criteria
Cases in which the principal investigator determines that participation in this study is inappropriate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of chemotherapy-induced peripheral neuropathy of Grade 2 or higher with or without proton pump inhibitor or H2-receptor antagonist use
- Secondary Outcome Measures
Name Time Method Time to onset of grade 2 or higher chemotherapy-induced peripheral neuropathy with and without use of proton pump inhibitors and H2-receptor antagonists, and percentage of chemotherapy intolerance due to chemotherapy-induced peripheral neuropathy